CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,000 | +5.0% | 856 | +9.3% | 0.00% | 0.0% |
| Q1 2022 | $20,000 | -76.5% | 783 | -66.4% | 0.00% | -66.7% |
| Q4 2021 | $85,000 | +97.7% | 2,331 | -6.9% | 0.00% | +50.0% |
| Q3 2021 | $43,000 | +22.9% | 2,505 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $35,000 | -73.7% | 2,590 | 0.0% | 0.00% | -71.4% |
| Q1 2021 | $133,000 | -18.9% | 2,590 | -2.0% | 0.01% | -22.2% |
| Q4 2020 | $164,000 | +10.8% | 2,642 | -2.3% | 0.01% | -10.0% |
| Q3 2020 | $148,000 | -4.5% | 2,705 | +0.3% | 0.01% | -9.1% |
| Q2 2020 | $155,000 | +38.4% | 2,696 | -3.1% | 0.01% | +10.0% |
| Q1 2020 | $112,000 | – | 2,782 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |